Breaking News
October 20, 2018 - Pounds Regained After Weight-Loss Op Can Tell Your Doc a Lot
October 20, 2018 - Sending parents letters to fight childhood obesity doesn’t work
October 20, 2018 - Supervised aerobic exercise can support major depression treatment
October 20, 2018 - Mindfulness-based program effective for reducing stress in infertile women
October 20, 2018 - Molecule capable of halting and reverting neurodegeneration caused by Parkinson’s disease identified
October 20, 2018 - Midazolam-mediated alterations of PER2 expression may have functional consequences during myocardial ischemia
October 20, 2018 - Sweat bees are ideal for studying the genes underlying social behavior
October 20, 2018 - Weight loss success associated with brain areas involved in self-control
October 20, 2018 - KHN’s ‘What the Health?’ Republicans’ preexisting political problem
October 20, 2018 - Research provides a more complete picture of suffering caused by terrorist attacks
October 20, 2018 - Eradicating Helicobacter pylori infections may be a key treatment for Parkinson’s disease
October 20, 2018 - Breast Cancer as a Dynamic Disease
October 20, 2018 - University of Pittsburgh wins NSF grant for big data research to prevent complications from anesthesia
October 20, 2018 - Skin-to-skin contact may promote attachment between parents and preterm infants
October 20, 2018 - Recommendations Developed to Verify NGT Placement in Children
October 20, 2018 - Weight loss can be boosted fivefold thanks to novel mental imagery technique
October 20, 2018 - Children with autism are more likely to be overweight, obese
October 20, 2018 - Nurses making conscientious objections to ethically-relevant policies lack support
October 20, 2018 - Prion strain diversity may be greater than previously thought
October 20, 2018 - Antidepressant treatment may lead to improvements in sleep quality of patients with depression
October 20, 2018 - Study reports increased risk of death in children with inflammatory bowel disease
October 20, 2018 - Number of Autism Genes Now Tops 100
October 20, 2018 - Total diet replacement programmes are effective for treating obesity
October 20, 2018 - CLARIOstar used for fluorescence measurements on CSIRO’s purpose-built research vessel
October 20, 2018 - People with more copies of AMY1 gene digest starchy carbohydrates faster
October 20, 2018 - Case Comprehensive Cancer Center wins NIH grant to study health disparities
October 20, 2018 - Newly discovered compound shows potential for treating Parkinson’s disease
October 20, 2018 - High rate of non-adherence to hormonal therapy found among premenopausal early breast cancer patients
October 20, 2018 - Immunotherapy medicine found to be effective in treating uveitis
October 20, 2018 - The Pistoia Alliance Calls for Greater Collaboration to Realise Benefits of Innovation and Announces Winners of the 2018 President’s Startup Challenge
October 20, 2018 - Female internists consistently earn less than men
October 20, 2018 - Stanford team looks at dangers of teens’ vaping habits
October 20, 2018 - New approach to understanding cancers will accelerate development of better treatments
October 20, 2018 - LJI and UC San Diego awarded $ 4.5 million as part of NCI’s Cancer Moonshot initiative
October 20, 2018 - School-based HPV vaccination did not increase risky sexual behaviors among adolescent girls
October 20, 2018 - Eye discovery to pave way for more successful corneal transplants
October 20, 2018 - New analysis examines the importance of location in the opioid crisis
October 20, 2018 - Green filters increase reading speed for children with dyslexia
October 19, 2018 - Bariatric Sx Cuts Macrovascular Complications in Obesity, T2DM
October 19, 2018 - Better assessments for early age-related macular degeneration
October 19, 2018 - Visible and valued: Stanford Medicine’s first-ever LGBTQ+ Forum | News Center
October 19, 2018 - Understanding of metal-free enzymes used by bacteria could lead to new effective antibiotics
October 19, 2018 - Beckman Coulter Life Sciences announces new research-focused website
October 19, 2018 - Study finds link between refined soluble fibers, gut microbiota and liver cancer
October 19, 2018 - Social media reduces risk of depression among seniors with pain
October 19, 2018 - Newly developed synthetic DNA molecule may one day be used as ‘vaccine’ for prostate cancer
October 19, 2018 - Preoperative weight loss may not provide health benefits after surgery
October 19, 2018 - U.S. Birth Rates Continue to Drop as Age of New Moms Rises
October 19, 2018 - New technology can keep an eye on babies’ movements in the womb
October 19, 2018 - Juul e-cigarettes pose addiction risk for young users | News Center
October 19, 2018 - Gene sequencing reveals crucial molecular aspects of Trypanosoma brucei
October 19, 2018 - New DNA vaccine strategy protects mice against lethal challenge by multiple H3N2 viruses
October 19, 2018 - Study shows close link between cytokine interleukin-1ß and obesity-promoted colon cancer
October 19, 2018 - Muscle mass plays a critical role in health, shows research
October 19, 2018 - Study finds undiagnosed prediabetes in many infertile men
October 19, 2018 - The Current issue of “The view from here” is concerned with Nanotherapeutic strategies
October 19, 2018 - Delay in replacing the Pap smear with HPV screening is costing lives
October 19, 2018 - Physicians battle pediatric diseases of ear, nose, throat in Zimbabwe | News Center
October 19, 2018 - Researchers investigate why some cancers affect only young women
October 19, 2018 - Drugmakers funnel millions to lawmakers; a few dozen get $100,000-plus
October 19, 2018 - Unselfish people tend to have more children and receive higher salaries
October 19, 2018 - New findings reveal potential cellular players in tumor microenvironment
October 19, 2018 - Study reveals impact of Juul use on teenagers and young adults
October 19, 2018 - Green leafy vegetables could help reduce macular degeneration risk
October 19, 2018 - Some countries take more time for reimbursement decisions on new cancer drugs
October 19, 2018 - Human brain cell transplant offers insights into neurological conditions
October 19, 2018 - Parental education associated with increased family health care spending
October 19, 2018 - New statistical method estimates long- and short-term risk of recurrence of breast cancer in US women
October 19, 2018 - Father’s exposure to nicotine may cause cognitive deficits in descendants
October 19, 2018 - Could we prevent Alzheimer’s disease by treating herpes?
October 19, 2018 - Nurse-led care can be more successful in managing gout
October 19, 2018 - Trump administration, pharma exchange verbal volleys on drug-price transparency
October 19, 2018 - Duke researchers find way to detect blood doping in athletes
October 19, 2018 - Many primary care doctors are still prescribing sedative drugs for older adults
October 19, 2018 - Finger length can predict sexuality in women say researchers
October 19, 2018 - Study finds differences in side-effects experienced by male and female OG cancer patients
October 19, 2018 - Dysfunction of single gene leads to miscarriages
October 19, 2018 - Few Seniors Who Self-Harm Referred for Mental Health Care
October 19, 2018 - Don’t sweat the sweet stuff
October 19, 2018 - URMC researchers discover new approach to deliver therapeutics to the brain
Mapping the Genes Responsible for Pluripotency

Mapping the Genes Responsible for Pluripotency

image_pdfDownload PDFimage_print

An interview with Atilgan Yilmaz, PhD, conducted by Kate Anderton, BSc

What are parthenogenetic haploid human pluripotent stem cells (hPSCs)? How do they differ from normal embryonic stem cells?

Pluripotent stem cells are those that are located in the inner cell mass of the early embryo. They are present within the first week of development and can develop into virtually any adult cell type in the human body.

Credit: Kateryna Kon/Shutterstock.com

Ploidy refers to the number of chromosomes present. Normal embryonic stem cells comprise two sets of chromosomes, one from the mother, and one from the father. Haploid cells contain a single copy of the genome, from one parent.

Parthenogenetic haploid human stem cells are those which contain only the maternal copy of the genome. They are generated using human oocytes which are activated chemically or using electrical stimuli. By activating these oocytes we can obtain early embryos which would otherwise fail later on and isolate the resulting pluripotent stem cells.

Overall, parthenogenetic haploid human pluripotent stem cells are very similar to diploid human embryonic stem cells in the genes that they express and their capacity to differentiate.

However, there are some minor differences.

For instance, diploidy allows for genomic imprinting. This is where only the maternal or paternal copy of the gene is expressed. Often, the expression of these genes is controlled by the dominant allele, so parthenogenetic haploid human pluripotent stem cells lack paternally imprinted genes because there’s no contribution from the sperm (and therefore the father) in these cells.

Another interesting difference with these cells is that normal diploid embryonic stem cells which are, let’s say female, will include two X chromosomes. However, because these are haploid cells, only one X chromosome originating from the oocyte is used.

As this is the only X chromosome, there’s no option of deactivating it, which somewhat raises the expression of the X chromosome relative to the rest of the genes. The ratio of X chromosome genes versus the autosomes is thus higher in haploid human embryonic stem cells.

Please describe the methodology you used to create the hPSCs.

The oocytes are tricked into the fertilization process. This involves extracting mature metaphase two oocytes from human donors which were activated using either chemical methods, such as calcium ionophores, or electrical pulses.

Following this, the cells start dividing in order to generate the early embryo. The embryos, or the oocytes, are then allowed to develop up to the blastocyst stage of the embryo, which contains the inner cell mass, from which we can isolate the embryonic stem cells.

How were you able to prove that the hPSCs were pluripotent?

Pluripotent cells are those which can differentiate into any adult cell type in the human body. Proving it involves the generation of multiple cell types from the same hPSC line and this is exactly what was done in the study we published in Nature two years ago.

We showed that the cells were able to differentiate into examples of the three main germ layers of the embryo; endoderm, ectoderm and mesoderm, as well as specific cell types from each germ layer.

Our study also showed these cells could not only differentiate into specific cell types, but they were also able to retain their haploidy during differentiation. This was interesting to observe as it directly contrasted what was previously shown in a mouse model.

A few years ago, these isolated cells were injected into animals for an assay called teratoma formation. Teratoma assays are one of the best assays for demonstrating the pluripotency of cells. The assay enables cells injected into mice to differentiate in vivo in a tissue environment.

Once teratoma tumours form, they are checked to see whether any pluripotent cells remain in the tissue, or whether all of them were able to differentiate into a germ layer.

When this assay was carried out, nearly all of the cells were found to have differentiated and the expression of pluripotency markers had diminished.

Why are hPSCs such an advancement in research?

hPSCs are an efficient tool for studying gene function. Haploid cells only have one copy of each gene, and if that single copy is mutated there won’t be any backup to confuse the readout of the experiments. Therefore, it is a very clean system for deactivating genes and studying their function.

Please describe your recent research in the field of stem cell genomics

Advanced developments in genetic technologies, such as CRISPR/Cas9, allowed us to target every single gene in the human genome, and study their function in the context of the growth of human embryonic stem cells.

We were able to establish which out of the nearly 20,000 genes in the human genomes supports the growth or the survival of these cells, and which proportion puts them at a disadvantage. Think of it as a Darwinian experiment in which we took a large pool of cells and mutated a different gene in every single cell.

Using a large gene-editing tool, we reached close to the full human genome and targeted more than 18,000 genes. We turned them off throughout different cells and allowed the cells to grow.

We analyzed the cell populations at the beginning and the end, and found that around nine percent of the entire human genome is essential for the normal growth and survival of human embryonic stem cells. Removing this percentage of roughly 18,000 genes would thus be detrimental to cell growth.

Meanwhile, another finding showed that if a different five percent of genes are removed, cells experience accelerated growth, meaning they restrict the growth of these cells when functioning normally.

This is the general view of the study, though we also found that among the essential genes, 9% cause autosomal recessive human disorders that have a growth retardation phenotype. We found that one fifth of these disorders can often affect the growth of the human embryonic stem cells.

How did you use CRISPR-Cas9 in your research?

We utilized a CRISPR-Cas9 tool set that was generated in a previous study. We had roughly ten guide RNAs for each gene we targeted, meaning we used a pool of 180,000 different guide RNAs in total. The guide RNAs were introduced into the cells using a lentivirus.

We were the first to use karyotypically normal cells with a stable genome, giving more medical meaning to this study. Using the CRISPR/Cas9 and gene editing technology on haploid embryonic stem cells was another novel feature of our research that set it apart from previous studies.

What areas of research can the newly generated “atlas of the human genome” be applied to?

There are many groups in several institutions that work on the functions of single genes. What we did here was basically generate this atlas of the human genome, which describes the necessary genes for embryonic development.  

Let’s say someone is working on a gene that we identified to be essential for the growth of any cell type. Using our data, they could easily find out the function of that gene and use it as a starting point for their research.

Secondly, studies regarding certain human genetic disorders with growth retardation phenotypes might benefit from an additional cell culture model because, as I said earlier, we showed that for around one fifth of such human genetic disorders, the genes causing these disorders affect the growth of the human embryonic stem cells.

This means we can use embryonic stem cells to study the growth phenotypes of these diseases instead of trying to differentiate the specific cell types affected in that disease.

Furthermore, even though recent decades of research have identified lots about pluripotency, we still don’t have a complete picture. I think our research will help achieve a comprehensive understanding of pluripotent stem cells. Aside from clinical applications, we also want to use hPSCs to understand early human development from a basic science point of view.

Our study has established a smaller group of genes that are specifically expressed in human embryonic stem cells, and identified the genes or gene networks needed to be pluripotent. This is a very important step towards understanding pluripotency on the genetic level and what networks are necessary for developing this plastic nature.

Credit: Vshivkova/Shutterstock.com

What are the next steps for your research?

Research always opens up more questions and we’re lucky to have so much data from our research and so many leads to follow. Some of the essential genes that we defined specifically for human embryonic stem cells were either not inadequately characterized or not characterized at all before our study. Now, we want to learn more about their function and their effects on pluripotency.

We have also developed a tool to study and explore genetic screens. Positive selection screens have a big pool of mutant cells each with a different mutation, and then a drug, such as a toxic drug used for chemotherapy for example, is used which kills most of the cells. Those that survive will have some sort of resistance because of the mutation.

By running such genetic screens, we can identify mechanisms of different drugs that are used in medicine. For instance, we could use the tool as a model to study chemotherapy resistance, or the developmental roles of particular genes in the embryo.

Where can readers find more information?

About Dr Atilgan Yilmaz

Atilgan is a postdoctoral fellow at the Azrieli Center for Stem Cells and Genetic Research at the Hebrew University of Jerusalem.

He completed his doctoral studies at the Department of Molecular Biology, Cell Biology and Biochemistry at Brown University working on a therapy model of Duchenne Muscular Dystrophy and a novel cell signaling pathway in muscle cell progenitors and differentiated muscle cells.

Following his doctoral studies, he moved to the Department of Biosystems Science and Engineering at ETH Zurich to pursue a postdoctoral position in which he explored the reversal of cell state in differentiated muscle cells by either genetic or pharmacological induction.

His current research focuses on understanding pluripotency and cell-state transitions during early human development.

Tagged with:

About author

Related Articles